EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted next-generation sequencing for comprehensive diagnosis and drug resistance detection in pulmonary and extrapulmonary tuberculosis: a single-center retrospective study

Jingyi Dai iD, Qiujing Li iD, Juan Wan, Fengshuo Sun iD, Gang Zhou, Meiqiu Yang, Chuanshu Dong, Yao Fang, Lifeng Li, Lin Wang iD, Guiming Liu iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.01698-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Jingyi Dai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Laboratory, The Third People's Hospital of Kunming City/Infectious Disease Clinical Medical Center of Yunnan Province, Kunming, …. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Mycobacterium tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Pathogen and Biosecurity open research project, Yunnan Province Major Science and Technology Special Plan, Clinical Medical Center Scientific Research Project of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB), including drug-resistant forms, is a significant global health issue requiring accurate and rapid diagnostic tools. Traditional diagnostic methods suffer from low sensitivity and slow results, while nucleic acid amplification tests (NAATs) like Xpert MTB/RIF provide faster but incomplete solutions. Targeted next-generation sequencing (tNGS) has the potential to simultaneously detect Mycobacterium tuberculosis , drug resistance mutations, and co-infecting pathogens. This study evaluates the effectiveness of tNGS for TB detection across various pulmonary and extrapulmonary TB samples. We retrospectively enrolled 159 patients with suspected TB at Kunming Third People’s Hospital. Specimens included 126 pulmonary and 33 extrapulmonary samples. All samples underwent tNGS, and results were compared against conventional microbiological tests and NAATs. tNGS demonstrated high diagnostic sensitivity for both pulmonary TB and extrapulmonary TB, achieving 83.9% sensitivity in bronchoalveolar lavage fluid, 89.5% in sputum, and 100% in extrapulmonary samples. tNGS showed an 83.3% agreement with Xpert in detecting rifampicin resistance. Additionally, tNGS also identified 22 drug resistance mutations, which are critical for predicting multidrug-resistant TB and pre-extensively drug-resistant TB. Additionally, tNGS effectively detected co-infecting respiratory pathogens, enhancing the understanding of complex TB cases. tNGS offers a highly sensitive and comprehensive approach for detecting TB and drug resistance, outperforming traditional methods in both pulmonary and extrapulmonary samples. It effectively identifies co-infections, providing a holistic view that enhances patient management, particularly in cases involving multidrug-resistant strains. These findings underscore tNGS’s potential to improve TB diagnostics and patient management through faster and more precise detection methods. IMPORTANCE Tuberculosis (TB) continues to be a leading cause of morbidity and mortality worldwide, particularly among marginalized populations. Timely and accurate diagnosis of TB, particularly extrapulmonary TB, remains challenging in low-resource settings, primarily due to non-specific clinical presentations that hinder early suspicion, along with limitations in both diagnosis and drug resistance detection. Additionally, targeted next-generation sequencing can identify co-infections with other clinically relevant pathogens, providing a more comprehensive understanding of each patient’s infectious profile. By leveraging advanced sequencing technologies, our findings highlight a powerful diagnostic approach that can improve TB diagnosis, support appropriate treatment strategies, and may increasingly benefit patients in underserved settings as sequencing platforms become more accessible and costs continue to decrease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingMycobacterium tuberculosisTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantHumansRetrospective StudiesTuberculosis, ExtrapulmonaryFemaleSensitivity and SpecificityMaleAdultMiddle AgedAntitubercular AgentsDrug Resistance, BacterialRifampinMutationSputumYoung AdultAgedMolecular Diagnostic TechniquesBronchoalveolar Lavage Fluid

Stichwörter der Autor:innen

diagnostic performancedrug resistancepulmonary and extrapulmonary samplestargeted next-generation sequencingtuberculosis

Substanzen

Antitubercular AgentsRifampin

Autor:innen und Institutionen

  • Department of Public Laboratory, The Third People's Hospital of Kunming City/Infectious Disease Clinical Medical Center of Yunnan Province, Kunming, Yunnan, People's Republic of China.
  • International Research Fellow, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Genskey Medical Technology Co., Ltd, Beijing, People's Republic of China.
  • College of Life Sciences, Peking University, Beijing, People's Republic of China.
  • Department of Medical Laboratory, The Third People's Hospital of Kunming City/Infectious Disease Clinical Medical Center of Yunnan Province, Kunming, Yunnan, People's Republic of China.

ORCID-Profile: Jingyi Dai, Qiujing Li, Fengshuo Sun, Lin Wang, Guiming Liu

Förderung

  • State Key Laboratory of Pathogen and Biosecurity open research project
  • Yunnan Province Major Science and Technology Special Plan
  • Clinical Medical Center Scientific Research Project of Yunnan Province
  • Kunming Science and Technology Bureau

Zitieren

APA

Dai, J., Li, Q., Wan, J., Sun, F., Zhou, G., Yang, M., Dong, C., Fang, Y., Li, L., Wang, L., & Liu, G. (2026). Targeted next-generation sequencing for comprehensive diagnosis and drug resistance detection in pulmonary and extrapulmonary tuberculosis: a single-center retrospective study. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01698-25

Vancouver

Dai J, Li Q, Wan J, Sun F, Zhou G, Yang M, et al. Targeted next-generation sequencing for comprehensive diagnosis and drug resistance detection in pulmonary and extrapulmonary tuberculosis: a single-center retrospective study. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01698-25

BibTeX
@article{Dai2026,
  author = {Dai, Jingyi and Li, Qiujing and Wan, Juan and Sun, Fengshuo and Zhou, Gang and Yang, Meiqiu and Dong, Chuanshu and Fang, Yao and Li, Lifeng and Wang, Lin and Liu, Guiming},
  title = {Targeted next-generation sequencing for comprehensive diagnosis and drug resistance detection in pulmonary and extrapulmonary tuberculosis: a single-center retrospective study},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.01698-25}
}
Kostenlos starten →